Development of assays for HTS to identify inhibitors of a new PPI involved in cancer metastasis
Development of assays for HTS to identify inhibitors of a new PPI involved in cancer metastasis
批准号:
9311182
负责人:
Celine DerMardirossian
金额:
$44.03万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-04-01 至 2020-03-31
关键词:
ActinsAdverse effectsAffinityAreaAutomobile DrivingBasement membraneBindingBiologicalBiological AssayBiologyBreast Cancer CellBreast Cancer PatientBreast Cancer therapyCell surfaceCellsCellular StructuresCessation of lifeCollectionComplexCytoskeletonDataDetectionDevelopmentDevicesDiagnosisDrug TargetingExperimental DesignsExtracellular MatrixFluorescenceFluorescence Resonance Energy TransferFocal AdhesionsFunctional disorderFutureGoalsGuanineGuanine Nucleotide Exchange FactorsGuanosine Triphosphate PhosphohydrolasesHumanImpairmentIn VitroInvestigationKnowledgeLaboratoriesLeadLibrariesLifeMDA MB 231Malignant neoplasm of prostateMetastatic breast cancerMolecularNeoplasm MetastasisNude MicePatientsPeptidesPharmaceutical PreparationsPlayProcessProtein AnalysisProteinsResearch PersonnelRoleSavingsSeriesSignal PathwaySignal TransductionSignaling ProteinSpecificityTestingTherapeuticTimeToxic effectTreatment EfficacyTumor Cell MigrationVesicleassay developmentbasecancer cellcell motilitydesignexperimental studyfollow-uphigh throughput screeningimprovedin vivoinhibitor/antagonistinnovationleukemiamalignant breast neoplasmmigrationminiaturizeneoplastic cellnoveloutcome forecastoverexpressionpreventprotein protein interactionprotein transportresistance mechanismrhoscreeningsmall moleculesmall molecule inhibitorstable cell linetime usetraffickingtumortumor progressionuncontrolled cell growth
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Breast cancer is a global problem, with 1.3 million new cases diagnosed and 430,000 deaths each year
worldwide. Recently, researchers have begun developing exciting drugs to target the protein-protein interactions
(PPIs) that regulate metastasis-driving signaling pathways. PPIs are critical for cellular signal transductions that
play key roles in both normal and abnormal functions in cells. Changes in specificity and affinity of these
interactions can lead to cellular malfunctions, such as uncontrolled cell growth and/or cell migration. A critical
key in dissemination process is the ability of cells to coordinate signaling pathways with cytoskeleton dynamics.
As critical coordinators of the cytoskeleton machinery, GTPases and their regulator GEFs are key players for
cell movement. Many tumors show increased expression and/or activation of GTPases and GEFs. These
proteins play fundamental roles in several aspects of cancer progression, metastasis and poor prognosis. Our
long-term goals are to better understand the molecular mechanisms of GTPases in metastasis process and to
device more effective, less toxic breast cancer therapies. Our strong preliminary data produced in our laboratory
uncover a new protein-protein interaction critical in cell invasion and metastasis. The objective in this application
is to implement a pilot high-throughput screen (HTS) to identify small molecule inhibitors of these novel binding
partners that will represent potentially life-saving therapeutic leads for inhibiting cancer metastasis. Three
specific aims will be developed in this proposal: 1) Development of fluorescence assay to detect this PPI; 2) Pilot
screen: Complete pilot screen against a compound collection of 20,000 compounds and follow up assays; 3)
Biological effects: perform initial characterization of active compounds on cell migration and invasion.
Our HTS will involve an innovative approach that analyzes PPIs in cells and improve scientific knowledge
about key signaling proteins in cell migration. This investigation will have substantial significance in
understanding fundamental and defined features of cell motility, with implications for many areas of biology and
pathophysiology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RhoGDI: yin and yang of RhoGTPases cycle
-
批准号:8372066
-
项目类别:
-
资助金额:$36.01万
-
财政年份:2012
-
负责人:Celine DerMardirossian
-
依托单位:
RhoGDI: yin and yang of RhoGTPases cycle
-
批准号:8551673
-
项目类别:
-
资助金额:$34.74万
-
财政年份:2012
-
负责人:Celine DerMardirossian
-
依托单位:
RhoGDI: yin and yang of RhoGTPases cycle
-
批准号:8911838
-
项目类别:
-
资助金额:$36.01万
-
财政年份:2012
-
负责人:Celine DerMardirossian
-
依托单位:
RhoGDI: yin and yang of RhoGTPases cycle
-
批准号:8728950
-
项目类别:
-
资助金额:$36.01万
-
财政年份:2012
-
负责人:Celine DerMardirossian
-
依托单位:
Cofilin/ADF Regulation in Rho GTPase Signaling
-
批准号:8081155
-
项目类别:
-
资助金额:$3.15万
-
财政年份:2010
-
负责人:Celine DerMardirossian
-
依托单位:
Dynamic Analysis of Rho GTPase-Rho GDI Cycling
-
批准号:7932880
-
项目类别:
-
资助金额:$52.34万
-
财政年份:2009
-
负责人:Celine DerMardirossian
-
依托单位:
Dynamic Analysis of Rho GTPase-Rho GDI Cycling
-
批准号:7739319
-
项目类别:
-
资助金额:$59.09万
-
财政年份:2009
-
负责人:Celine DerMardirossian
-
依托单位:
Cofilin/ADF Regulation in Rho GTPase Signaling
-
批准号:7874651
-
项目类别:
-
资助金额:$42.96万
-
财政年份:1991
-
负责人:Celine DerMardirossian
-
依托单位:
Cofilin/ADF Regulation in Rho GTPase Signaling
-
批准号:7644481
-
项目类别:
-
资助金额:$43.4万
-
财政年份:1991
-
负责人:Celine DerMardirossian
-
依托单位:
G Protein Regulation of the Neutrophil NADPH Oxidase
-
批准号:7652547
-
项目类别:
-
资助金额:$71.1万
-
财政年份:1991
-
负责人:Celine DerMardirossian
-
依托单位:
G Protein Regulation of the Neutrophil NADPH Oxidase
-
批准号:7851364
-
项目类别:
-
资助金额:$72.67万
-
财政年份:1991
-
负责人:Celine DerMardirossian
-
依托单位:
Regulation of neutrophil receptor G protein interactions
-
批准号:7534957
-
项目类别:
-
资助金额:$52.68万
-
财政年份:1988
-
负责人:Celine DerMardirossian
-
依托单位:
海外基金